Stay updated on Tislelizumab Combo in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Tislelizumab Combo in NSCLC Clinical Trial page.

Latest updates to the Tislelizumab Combo in NSCLC Clinical Trial page
- ChecktodayChange DetectedSponsor/organization name updated: 'BeOne Medicines (BeiGene)' was added and the former 'BeiGene' entry removed. This update appears in version 29 with dates around December 2025 (2025-12-10 to 2025-12-15).SummaryDifference0.4%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page shows a minor site revision update: 'Revision: v3.3.2' was added and 'Revision: v3.3.1' was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check22 days agoChange DetectedThe page history now includes a new revision entry (v3.3.1) and removes the previous v3.2.0 entry, updating the revision list. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check29 days agoChange DetectedThe government funding/operating status notice shown on the page has been removed; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check43 days agoChange DetectedThe old and new screenshots show a redesigned header and minor layout adjustments; core content such as study data and version history remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check72 days agoChange DetectedUpgrade to v3.2.0 with a government operating-status notice and links to status pages; removes the previous v3.1.0 reference.SummaryDifference11%

Stay in the know with updates to Tislelizumab Combo in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tislelizumab Combo in NSCLC Clinical Trial page.